Crossmark

Dynorphin‐based “release on demand” gene therapy for drug‐resistant temporal lobe epilepsy

Crossref DOI link: https://doi.org/10.15252/emmm.201809963

Published Online: 2019-09-05

Published Print: 2019-10

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Agostinho, Alexandra S

Mietzsch, Mario

Zangrandi, Luca

Kmiec, Iwona

Mutti, Anna

Kraus, Larissa

Fidzinski, Pawel

Schneider, Ulf C

Holtkamp, Martin

Heilbronn, Regine https://orcid.org/0000-0001-6412-3278
Schwarzer, Christoph https://orcid.org/0000-0002-6373-3717
Funding

Funding for this research was provided by:

Austrian Science Fund (I‐977)

Austrian Science Fund (P‐30592)

Austrian Science Fund (W‐1206)

Deutsche Forschungsgemeinschaft (DFG He1598/9‐1)
License Information

Version of Record valid from 2019-09-05
More Information

Publication History

Received: 2018-10-20

Accepted: 2019-08-06

Published: 2019-09-05